278 related articles for article (PubMed ID: 16409196)
1. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood.
Eng PA; Borer-Reinhold M; Heijnen IA; Gnehm HP
Allergy; 2006 Feb; 61(2):198-201. PubMed ID: 16409196
[TBL] [Abstract][Full Text] [Related]
2. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
Roberts G; Hurley C; Turcanu V; Lack G
J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
[TBL] [Abstract][Full Text] [Related]
3. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children.
Rolinck-Werninghaus C; Hamelmann E; Keil T; Kulig M; Koetz K; Gerstner B; Kuehr J; Zielen S; Schauer U; Kamin W; Von Berg A; Hammermann J; Weinkauf B; Weidinger G; Stenglein S; Wahn U;
Allergy; 2004 Sep; 59(9):973-9. PubMed ID: 15291906
[TBL] [Abstract][Full Text] [Related]
4. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of preseasonal grass pollen immunotherapy in children.
Eng PA; Reinhold M; Gnehm HP
Allergy; 2002 Apr; 57(4):306-12. PubMed ID: 11906360
[TBL] [Abstract][Full Text] [Related]
6. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
7. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis.
Dahl R; Stender A; Rak S
Allergy; 2006 Feb; 61(2):185-90. PubMed ID: 16409194
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical efficacy of grass-pollen immunotherapy.
Durham SR; Walker SM; Varga EM; Jacobson MR; O'Brien F; Noble W; Till SJ; Hamid QA; Nouri-Aria KT
N Engl J Med; 1999 Aug; 341(7):468-75. PubMed ID: 10441602
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
[TBL] [Abstract][Full Text] [Related]
10. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
[TBL] [Abstract][Full Text] [Related]
11. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy.
Kopp MV; Hamelmann E; Bendiks M; Zielen S; Kamin W; Bergmann KC; Klein C; Wahn U;
Pediatr Allergy Immunol; 2013 Aug; 24(5):427-33. PubMed ID: 23799935
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.
Kopp MV; Stenglein S; Kamin W; Friedrichs F; von Berg A; Zielen S; Hamelmann E; Wahn U; Kuehr J
Pediatr Allergy Immunol; 2007 Sep; 18(6):523-7. PubMed ID: 17680911
[TBL] [Abstract][Full Text] [Related]
13. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial.
Walker SM; Pajno GB; Lima MT; Wilson DR; Durham SR
J Allergy Clin Immunol; 2001 Jan; 107(1):87-93. PubMed ID: 11149996
[TBL] [Abstract][Full Text] [Related]
14. Does specific immunotherapy injection cause an increase in bronchial reactivity?
Keskin O; Tuncer A; Yildirim S; Bursali B; Adalioglu G; Sekerel BE
J Asthma; 2005 Nov; 42(9):765-8. PubMed ID: 16316871
[TBL] [Abstract][Full Text] [Related]
15. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.
Niggemann B; Jacobsen L; Dreborg S; Ferdousi HA; Halken S; Høst A; Koivikko A; Koller D; Norberg LA; Urbanek R; Valovirta E; Wahn U; Möller C;
Allergy; 2006 Jul; 61(7):855-9. PubMed ID: 16792584
[TBL] [Abstract][Full Text] [Related]
16. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.
Rolinck-Werninghaus C; Wolf H; Liebke C; Baars JC; Lange J; Kopp MV; Hammermann J; Leupold W; Bartels P; Gruebl A; Bauer CP; Schnitker J; Wahn U; Niggemann B
Allergy; 2004 Dec; 59(12):1285-93. PubMed ID: 15507097
[TBL] [Abstract][Full Text] [Related]
18. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
Novembre E; Galli E; Landi F; Caffarelli C; Pifferi M; De Marco E; Burastero SE; Calori G; Benetti L; Bonazza P; Puccinelli P; Parmiani S; Bernardini R; Vierucci A
J Allergy Clin Immunol; 2004 Oct; 114(4):851-7. PubMed ID: 15480326
[TBL] [Abstract][Full Text] [Related]
19. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis.
Williams A; Henzgen M; Rajakulasingam K
Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):123-6. PubMed ID: 17523386
[TBL] [Abstract][Full Text] [Related]
20. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
Klimek L; Mewes T; Wolf H; Hansen I; Schnitker J; Mann WJ
Otolaryngol Head Neck Surg; 2005 Oct; 133(4):538-43. PubMed ID: 16213926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
